Cargando…
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
BACKGROUND: The pathological and clinical features of invasive lobular carcinoma (ILC) differ from those of invasive ductal carcinoma (IDC). Several studies have indicated that patients with ILC have a better prognosis than those with ductal carcinoma. However, no previous study has considered the m...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807554/ https://www.ncbi.nlm.nih.gov/pubmed/27015895 http://dx.doi.org/10.1186/s12885-016-2275-4 |
_version_ | 1782423395159244800 |
---|---|
author | Adachi, Yayoi Ishiguro, Junko Kotani, Haruru Hisada, Tomoka Ichikawa, Mari Gondo, Naomi Yoshimura, Akiyo Kondo, Naoto Hattori, Masaya Sawaki, Masataka Fujita, Takashi Kikumori, Toyone Yatabe, Yasushi Kodera, Yasuhiro Iwata, Hiroji |
author_facet | Adachi, Yayoi Ishiguro, Junko Kotani, Haruru Hisada, Tomoka Ichikawa, Mari Gondo, Naomi Yoshimura, Akiyo Kondo, Naoto Hattori, Masaya Sawaki, Masataka Fujita, Takashi Kikumori, Toyone Yatabe, Yasushi Kodera, Yasuhiro Iwata, Hiroji |
author_sort | Adachi, Yayoi |
collection | PubMed |
description | BACKGROUND: The pathological and clinical features of invasive lobular carcinoma (ILC) differ from those of invasive ductal carcinoma (IDC). Several studies have indicated that patients with ILC have a better prognosis than those with ductal carcinoma. However, no previous study has considered the molecular subtypes and histological subtypes of ILC. We compared prognosis between IDC and classical, luminal type ILC and developed prognostic factors for early breast cancer patients with classical luminal ILC. METHODS: Four thousand one hundred ten breast cancer patients were treated at the Aichi Cancer Center Hospital from 2003 to 2012. We identified 1,661 cases with luminal IDC and 105 cases with luminal classical ILC. We examined baseline characteristics, clinical outcomes, and prognostic factors of luminal ILC. RESULTS: The prognosis of luminal ILC was significantly worse than that of luminal IDC. The rates of 5-year disease free survival (DFS) were 91.9 % and 88.4 % for patients with luminal IDC and luminal ILC, respectively (P = 0.008). The rates of 5-year overall survival (OS) were 97.6 % and 93.1 % for patients with luminal IDC and luminal ILC respectively (P = 0.030). Although we analyzed prognosis according to stratification by tumor size, luminal ILC tended to have worse DFS than luminal IDC in the large tumor group. In addition, although our analysis was performed according to matching lymph node status, luminal ILC had a significantly worse DFS and OS than luminal IDC in node-positive patients. Survival curves showed that the prognosis for ILC became worse than IDC over time. Multivariate analysis showed that ILC was an important factor related to higher risk of recurrence of luminal type breast cancer, even when tumor size, lymph node status and histological grade were considered. CONCLUSIONS: Luminal ILC had worse outcomes than luminal IDC. Consequently, different treatment approaches should be used for luminal ILC than for luminal IDC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2275-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4807554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48075542016-03-25 Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma Adachi, Yayoi Ishiguro, Junko Kotani, Haruru Hisada, Tomoka Ichikawa, Mari Gondo, Naomi Yoshimura, Akiyo Kondo, Naoto Hattori, Masaya Sawaki, Masataka Fujita, Takashi Kikumori, Toyone Yatabe, Yasushi Kodera, Yasuhiro Iwata, Hiroji BMC Cancer Research Article BACKGROUND: The pathological and clinical features of invasive lobular carcinoma (ILC) differ from those of invasive ductal carcinoma (IDC). Several studies have indicated that patients with ILC have a better prognosis than those with ductal carcinoma. However, no previous study has considered the molecular subtypes and histological subtypes of ILC. We compared prognosis between IDC and classical, luminal type ILC and developed prognostic factors for early breast cancer patients with classical luminal ILC. METHODS: Four thousand one hundred ten breast cancer patients were treated at the Aichi Cancer Center Hospital from 2003 to 2012. We identified 1,661 cases with luminal IDC and 105 cases with luminal classical ILC. We examined baseline characteristics, clinical outcomes, and prognostic factors of luminal ILC. RESULTS: The prognosis of luminal ILC was significantly worse than that of luminal IDC. The rates of 5-year disease free survival (DFS) were 91.9 % and 88.4 % for patients with luminal IDC and luminal ILC, respectively (P = 0.008). The rates of 5-year overall survival (OS) were 97.6 % and 93.1 % for patients with luminal IDC and luminal ILC respectively (P = 0.030). Although we analyzed prognosis according to stratification by tumor size, luminal ILC tended to have worse DFS than luminal IDC in the large tumor group. In addition, although our analysis was performed according to matching lymph node status, luminal ILC had a significantly worse DFS and OS than luminal IDC in node-positive patients. Survival curves showed that the prognosis for ILC became worse than IDC over time. Multivariate analysis showed that ILC was an important factor related to higher risk of recurrence of luminal type breast cancer, even when tumor size, lymph node status and histological grade were considered. CONCLUSIONS: Luminal ILC had worse outcomes than luminal IDC. Consequently, different treatment approaches should be used for luminal ILC than for luminal IDC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2275-4) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-25 /pmc/articles/PMC4807554/ /pubmed/27015895 http://dx.doi.org/10.1186/s12885-016-2275-4 Text en © Adachi et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Adachi, Yayoi Ishiguro, Junko Kotani, Haruru Hisada, Tomoka Ichikawa, Mari Gondo, Naomi Yoshimura, Akiyo Kondo, Naoto Hattori, Masaya Sawaki, Masataka Fujita, Takashi Kikumori, Toyone Yatabe, Yasushi Kodera, Yasuhiro Iwata, Hiroji Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma |
title | Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma |
title_full | Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma |
title_fullStr | Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma |
title_full_unstemmed | Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma |
title_short | Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma |
title_sort | comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807554/ https://www.ncbi.nlm.nih.gov/pubmed/27015895 http://dx.doi.org/10.1186/s12885-016-2275-4 |
work_keys_str_mv | AT adachiyayoi comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT ishigurojunko comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT kotaniharuru comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT hisadatomoka comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT ichikawamari comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT gondonaomi comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT yoshimuraakiyo comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT kondonaoto comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT hattorimasaya comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT sawakimasataka comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT fujitatakashi comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT kikumoritoyone comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT yatabeyasushi comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT koderayasuhiro comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma AT iwatahiroji comparisonofclinicaloutcomesbetweenluminalinvasiveductalcarcinomaandluminalinvasivelobularcarcinoma |